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http://dx.doi.org/10.1016/j.bgm.201Abstract Research has shown drug resistance as the major cause of failure of cancer chemo-
therapy. In this study, doxorubicin-sensitive human uterine cancer cell (hUCC) MES/SA, as well
as doxorubicin-resistant hUCC MES/SA-DxR 2mM and MES/SA-DxR 8mM were used. Subsequently,
asparagine synthetase (ASNS), a protein that had previously been proposed to be a putative
cancer drug target in our laboratory, was silenced by siRNA knockdown to study the mechanism
of doxorubicin-induced resistance further. After potent knockdown of ASNS, cell viability in
two doxorubicin-resistant cell lines MES/SA-DxR 2mM and MES/SA-DxR 8mM was decreased, as
indicated by an MTT cell proliferation assay. By coupling two-dimensional differential gel elec-
trophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry,
proteins that play a vital role in ASNS signaling network and development of doxorubicin-
induced resistance were identified. Among all the proteins that we have identified, GRP78
and AKR1C1 appear to be involved in drug resistance, replication factor C appears to partici-
pate in DNA repairing, and PP6C is proposed to play a role in cell cycle arrest.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Drug resistance is one of the most difficult and stressful
problems during cancer treatment. Currently, multidrugof Applied Science, National
er 521, Nanda Road, Hsinchu
e.edu.tw (H.-C. Chou).
an Genomic Medicine and Bioma
3.07.003resistance (MDR) in cancer cells, after exposure to
chemotherapeutic drugs, exhibits the following four
phenomena: (1) upregulated topoisomerase II to facili-
tate recovery from DNA damage; (2) enhanced anti-
apoptotic Bcl-2 family members to inhibit apoptosis; (3)
overexpressed P-glycoprotein, also known as MDR1, to
pump out drugs from cytosol; and (4) altered drug
metabolism leading to the formation of noncytotoxic
metabolites.rker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 ASNS was detected by western blot in wild-type and
doxorubicin-resistant human uterine cancer cells.
ASNS Z asparagine synthetase; GAPDH Z glyceraldehyde 3-
phosphate dehydrogenase.
Asparagine synthetase and doxorubicin resistance 101Doxorubicin, an inhibitor of topoisomerase II, is an
anthracycline drug used widely in chemotherapy. Although
topoisomerase II can unlock the superhelix structure of DNA
and cut the double-stranded DNA, doxorubicin is able to
interact with DNA and inhibit the resynthesis of double-
stranded DNA during DNA replication, thereby eliminating
cancer cells. Nevertheless, cancer cells become resistant to
doxorubicin if it is used for a long period of time.
Our previous research indicated that asparagine syn-
thetase (ASNS) is upregulated in doxorubicin-resistant
human uterine cancer cell (hUCC).1 Nevertheless, ASNS
has already been known as a resistant marker in acute
lymphoblastic leukemia (ALL).2 For curing certain ALL that
lacks ASNS, L-asparaginase is a successful chemotherapy
drug by removing L-asparagine outside leukemia cells to
avoid exo-L-asparagine entering the cancer cell for further
protein synthesis and cell survival. However, some resistant
ALL cells begin to express ASNS because of gene mutation.
Our aim is to investigate the role of ASNS in the develop-
ment of doxorubicin-resistant hUCC and the related signal
transduction pathway.
Materials and methods
Cell lines and cell culture
During our study, the hUCC MESeSA, cell line MESeSA/DxR
2mM with lower doxorubicin resistance, and cell line
MESeSA/DxR 8mM with higher doxorubicin resistance were
cultured in McCoy’s 5a modified complete medium. All cells
were incubated at 37 C/5% CO2.
MTT cell viability assay
Cells were seeded in 96-well plates (8000 cells/well) and
incubated for 24 hours prior to treating with indicated
doxorubicin concentrations for 48 hours. After removing
doxorubicin, 100 mL MTT reagents (1 mg/mL) was added to
each well and incubated at 37 C/5% CO2 for 4 hours. The
supernatant was removed and 100 mL dimethyl sulfoxide
(DMSO) was added to stop the reaction. Absorbance of the
samples was measured at a wavelength of 545nM.
Transfection of siRNA
The target sequences against ASNS are 50-UAU CAG AUU
GGA AUC CUC AAA CGU C-30 and 50-UUG UUU GCU CAA UUC
CUC CUU UGU C-30. Cells were transfected with 100nM of
ASNS siRNA in a serum-free medium containing lipofect-
amine for 4 hours. Then the cells were recovered in
completed medium for 24 hours. Efficiency of siRNA
knockdown was detected by western blot.
Western blot
Cells were lysed with 1 NP40 and proteins were quantified
by the Bradford assay. Protein samples were diluted with
sample buffer and separated by 10% sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE). After
transferring separated proteins to Immobilon P membranes(with a pore size of 0.45 mm), the membranes were blocked
by 5% bovine serum albumin (BSA) for 1 hour. The mem-
branes were incubated with primary antibody against ASNS
for 24 hours and washed with tris-buffered saline and
tween 20 (TBS-T) (4  10 minutes), following which they
were incubated with secondary antibody for 1 hour and
washed again with TBS-T (6  15 minutes). Immunoreactive
proteins were detected by the chemiluminescence method.
Two-dimensional differential gel electrophoresis
and image analysis
The detailed experimental procedures for two-dimensional
differential gel electrophoresis (2D-DIGE) have been
described in our previous results.1 Briefly, protein samples
were labeled with N-hydroxysuccinimidyl ester derivatives
of the cyanine dyes Cy2, Cy3, and Cy5. Triplicate samples
and the internal standard were run and quantified on
multiple two-dimensional gel electrophoresis (2-DE).
Afterward, the fluorescent 2-DE was scanned using an Ettan
DIGE imager (GE Healthcare, Uppsala, Sweden), and gel
analysis was performed using DeCyder 2-D Differential
Analysis Software v7.0 (GE Healthcare, Uppsala, Sweden) to
co-detect, normalize, and quantify the protein features in
the images. Spots displaying an average-fold increase or
decrease of 1.5 in abundance with p < 0.05 were selected
for protein identification.
Protein staining and in-gel digestion
Colloidal Coomassie Blue G-250 was used to stain 2D gels,
and the protein spots were picked from the gel. After
vacuum drying, the protein spots were digested with 50 ng
trypsin in 10mM ammonium bicarbonate. Peptide extracts
were vacuum-dried and stored at e20 C.
Protein identification by matrix-assisted laser
desorption ionization time-of-flight mass
spectrometry
Peptide samples and standards were dissolved in 0.1% for-
mic acid, and then 1 mL of each sample was spotted on an
anchorchip target plate and fried. Then 1 mL matrix solu-
tion, containing hydroxycinnamic acid in 50% acetone
Table 1 ASNS knockdown-induced changes in protein profile.
GI number Gene name Protein name Functional ontology
86577744 HSPA5 78 kDa glucose-regulated proteindGRP-78 Protein folding
47115187 EEF1G Elongation factor 1-gammadEF-1-gamma Translational regulation
6969998 EIF4A1 Eukaryotic initiation factor 4A-IdeIF4A-I Translational regulation
74355161 ZNF624 Zinc finger protein 624 Transcriptional regulation
336455091 TTC34 Tetratricopeptide repeat protein 34dTPR repeat protein 34 Transcriptional regulation
49456715 ALDOA Fructose-bisphosphate aldolase A Metabolism
38091150 MOB3B MOB kinase activator 3BdMob1 homolog 2b Metal ion binding
5453543 AKR1C1 Aldoeketo reductase family 1 member C1 Protein regulation
110430928 EPB41 Protein 4.1dP4.1 Association with cytoskeleton
183603931 PPP6C Serine/threonine-protein phosphatase 6 catalytic subunit Protein folding
30353858 RFC1 Replication factor C subunit 1 Transcriptional regulation
102 L.-H. Lin et al.nitrile (ACN)/0.1% trifluoroacetic acid (TFA) (4 mg/mL),
was spotted and air dried. Peptide mass fingerprints were
analyzed using an Autoflex III mass spectrometer (Bruker
Daltonics, Bremen, Germany), and the raw data were
analyzed using Flex Analysis acquisition software (Bruker
Daltonics, Bremen, Germany). Mass peaks were used to
generate peptide mass fingerprints; for protein identifica-
tion, these fingerprints were searched against the Swiss-
Prot/TrEMBL database using Mascot software V2.2.06.
Results
Identification of ASNS in doxorubicin-resistant
hUCC and ASNS knockdown
To discover the relationship between ASNS and doxorubicin
resistance, hUCC MESeSA, MES–SA/DxR 2mM (lower doxoru-
bicin resistance), and MES–SA/DxR 8mM (higher doxorubicin
resistance) were used. Western blot showed that ASNS is
obviously upregulated in doxorubicin-resistant cells (Fig. 1).
Then 100nM siRNA was used to silence up to 80% of ASNS for 3
days in both doxorubicin-resistant cell lines (data not shown).
Analysis of cell viability to doxorubicin prior to and
after ASNS knockdown
After performing siRNA knockdown mentioned earlier,
treated cells were subsequently incubated with doxorubicin
for 48 hours. The MTT result showed that cell viability
decreased by 20% in both doxorubicin-resistant cell lines
after siRNA knockdown (data not shown).
Investigation of proteins related to ASNS expression
through 2D-DIGE
By comparing total protein expressions in these three cell
lines prior to and after ASNS knockdown, we could find out
theproteins that play crucial roles in thecontribution ofASNS
to doxorubicin resistance. Because gel images had higher
background interference, we performed the first analysis
prior to cutting and the second analysis after cutting the
background. Finally, 12 proteins have been identified, and
their functions including translation regulation,metabolism,
and protein folding have been classified (Table 1).Discussion
Our data show that ASNS is upregulated in doxorubicin-
resistant hUCC. In L-asparaginase-resistant ALL cells,
overexpressed ASNS contributes to the conversion of
asparagine to aspartate for further protein synthesis. The
same role of ASNS in doxorubicin-resistant hUCC can be
proposed. In this study, we further identified 12 differen-
tially expressed proteins in doxorubicin-resistant hUCC
after suppression of ASNS expression by siRNA. Two of these
proteins have been reported to be related to drug resis-
tance (GRP783 and AKR1C14), because both proteins are
overexpressed in certain cancer cells. Moreover, EIF4A-I
can control cell proliferation in melanoma cells.5 Other
proteins may also play roles in drug resistance, such as the
replication factor C6 is involved in DNA repairing and PP6C7
is related to cell cycle arrest. Although the role of some
identified proteins in drug resistance remains elusive, work
has been undertaken to explore their contribution to the
ASNS-mediated signaling network.References
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